Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2018 1
2019 2
2020 1
2021 2
2022 2
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan.
Hsieh SM, Liu MC, Chen YH, Lee WS, Hwang SJ, Cheng SH, Ko WC, Hwang KP, Wang NC, Lee YL, Lin YL, Shih SR, Huang CG, Liao CC, Liang JJ, Chang CS, Chen C, Lien CE, Tai IC, Lin TY. Hsieh SM, et al. Among authors: chang cs. Lancet Respir Med. 2021 Dec;9(12):1396-1406. doi: 10.1016/S2213-2600(21)00402-1. Epub 2021 Oct 13. Lancet Respir Med. 2021. PMID: 34655522 Free PMC article. Clinical Trial.
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan.
Chang JH, Chiou JF, Hung CS, Liu MC, Chang HW, Hong SY, Wang CY, Lin YL, Hsieh YC, Chung CL, Su YS, Hsiao SS, Liu D, Liang JJ, Liao CC, Chang CS, Lai KS, Chuang HC, Chien KL, Wu WC, Lee YG, Lin SE, Shen YK, Hsu CF, Wang JC, Hsiao SH. Chang JH, et al. Among authors: chang cs. Vaccines (Basel). 2022 Feb 17;10(2):312. doi: 10.3390/vaccines10020312. Vaccines (Basel). 2022. PMID: 35214770 Free PMC article.
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants.
Lee IJ, Sun CP, Wu PY, Lan YH, Wang IH, Liu WC, Yuan JP, Chang YW, Tseng SC, Tsung SI, Chou YC, Kumari M, Lin YS, Chen HF, Chen TY, Lin CC, Chiu CW, Hsieh CH, Chuang CY, Cheng CM, Lin HT, Chen WY, Hsu FF, Hong MH, Liao CC, Chang CS, Liang JJ, Ma HH, Chiang MT, Liao HN, Ko HY, Chen LY, Ko YA, Yu PY, Yang TJ, Chiang PC, Hsu ST, Lin YL, Lee CC, Wu HC, Tao MH. Lee IJ, et al. Among authors: chang cs. J Biomed Sci. 2022 Jul 7;29(1):49. doi: 10.1186/s12929-022-00830-1. J Biomed Sci. 2022. PMID: 35799178 Free PMC article.
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern.
Lee IJ, Lan YH, Wu PY, Wu YW, Chen YH, Tseng SC, Kuo TJ, Sun CP, Jan JT, Ma HH, Liao CC, Liang JJ, Ko HY, Chang CS, Liu WC, Ko YA, Chen YH, Sie ZL, Tsung SI, Lin YL, Wang IH, Tao MH. Lee IJ, et al. Among authors: chang cs. Emerg Microbes Infect. 2023 Dec;12(1):2149353. doi: 10.1080/22221751.2022.2149353. Emerg Microbes Infect. 2023. PMID: 36395071 Free PMC article.
11 results